Bloomberg

New Business

Cambricon shares slump 14%, the most in 7 months, as reality check hits investors

Cambricon Technologies, the artificial intelligence chipmaker dubbed “China’s Nvidia”, tumbled on Thursday as investors took profit from one of the…

Read More »
New Business

China advances development bank to help 10 Eurasian countries curb US dollar risks

A strong push on Monday to create a development bank serving 10 Eurasian countries, including China, would help insulate the…

Read More »
New Business

Chinese EV maker BYD’s profits fall as price war at home swamps surging overseas sales

China’s electric-vehicle (EV) king BYD reported a 30 per cent drop in profits in the second quarter as surging overseas…

Read More »
New Business

Changing times: Cambricon tops Moutai as China’s costliest stock as chips trump baijiu

Cambricon Technologies became the costliest stock in mainland China’s equities market, as the Beijing-based chipmaker replaced the liquor distiller Kweichow…

Read More »
New Business

Ether hits record high as rate-cut expectations drive crypto rally

Ether surged to a record for the first time in almost four years, with the second-largest cryptocurrency benefiting from a…

Read More »
New Business

Hong Kong tops the US as the go-to IPO venue for Chinese start-ups as funds return to Asia

In the first of a two-part series about Hong Kong’s market for initial public offerings, Zhang Shidong and Ao Yulu…

Read More »
New Business

China’s shipments of major fertiliser surge 600%, signalling softer export curbs

Chinese shipments of urea – a major fertiliser and chemical used to reduce emissions – have surged after Beijing reportedly…

Read More »
New Business

Leapmotor’s stock and sales soar to become a new challenger in China’s booming EV market

Zhejiang Leapmotor Technology, once a fringe player in China’s electric vehicle (EV) industry, is beating all its start-up rivals by…

Read More »
New Business

Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits

Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…

Read More »
New Business

JPMorgan, UBS are positive on Hutchison as ports sale assurance eases investors’ concern

Financial analysts said they were positive on the outlook for CK Hutchison Holdings after the conglomerate said its controversial ports…

Read More »
Back to top button